H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells.
In recent years, the highly pathogenic avian influenza virus H5N1 has raised serious worldwide concern about an influenza pandemic; however, the biology of H5N1 pathogenesis is largely unknown. To elucidate the mechanism of H5N1 pathogenesis, we prepared primary airway epithelial cells from alveolar tissues from 1-year-old pigs and measured the growth kinetics of three avian H5 influenza viruses (A/Crow/Kyoto/53/2004 [H5N1], A/Duck/Hong Kong/342/78 [H5N2], and A/Duck/Hong Kong/820/80 [H5N3]), the resultant cytopathicity, and possible associated mechanisms. H5N1, but not the other H5 viruses, strongly induced cell death in porcine alveolar epithelial cells (pAEpC), although all three viruses induced similar degrees of cytopathicity in chicken embryonic fibroblasts. Intracellular viral growth and the production of progeny viruses were comparable in pAEpC infected with each H5 virus. In contrast, terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling-positive cells were detected only in H5N1-infected pAEpC, and the activities of caspases 3, 8, and 9 were significantly elevated in pAEpC infected with H5N1, but not with H5N2 and H5N3. These results suggest that only H5N1 induces apoptosis in pAEpC. H5N1 cytopathicity was inhibited by adding the caspase inhibitor z-VAD-FMK; however, there were no significant differences in viral growth or release of progeny viruses. Further investigations using reverse genetics demonstrated that H5N1 hemagglutinin protein plays a critical role in inducing caspase-dependent apoptosis in infected pAEpC. H5N1-specific cytopathicity was also observed in human primary airway epithelial cells. Taken together, these data suggest that avian H5N1 influenza virus leads to substantial cell death in mammalian airway epithelial cells due to the induction of apoptosis.
Daidoji
Tomo
T
International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Koma
Takaaki
T
Du
Anariwa
A
Yang
Cheng-Song
CS
Ueda
Mayo
M
Ikuta
Kazuyoshi
K
Nakaya
Takaaki
T
D000818:Animals; D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D002478:Cells, Cultured; D002645:Chickens; D003588:Cytopathogenic Effect, Viral; D004847:Epithelial Cells / Q000821:virology*; D005347:Fibroblasts; D006801:Humans; D020287:In Situ Nick-End Labeling; D053124:Influenza A Virus, H5N1 Subtype / Q000254:growth & development / Q000502:physiology*; D008969:Molecular Sequence Data; D012367:RNA, Viral / Q000235:genetics; D020545:Respiratory Mucosa / Q000821:virology*; D017422:Sequence Analysis, DNA; D013552:Swine
D012367:RNA, Viral; D020169:Caspases
J Immunol. 1999 Aug 15;163(4):2217-25
10438964
Lancet. 2004 Feb 21;363(9409):617-9
14987888
Nature. 2006 Mar 23;440(7083):435-6
16554799
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3064-9
18287069
J Virol. 2002 Feb;76(4):1617-25
11799156
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13849-54
12368467
Arch Virol. 2006 Jul;151(7):1267-79
16502281
Vaccine. 2007 Jul 26;25(30):5637-44
17126960
Virology. 1995 Jun 1;209(2):664-70
7778300
Nat Rev Cancer. 2002 Jun;2(6):420-30
12189384
Oncogene. 2003 Nov 24;22(53):8543-67
14634618
Lancet. 2006 Jan 7;367(9504):84
16399159
J Virol. 2007 Apr;81(7):3058-67
17229704
Emerg Infect Dis. 2005 Jul;11(7):1036-41
16022777
J Virol. 1998 Sep;72(9):7367-73
9696833
Pharm Res. 2006 Sep;23(9):2078-93
16952001
Am J Physiol Lung Cell Mol Physiol. 2002 Dec;283(6):L1315-21
12388377
EMBO J. 2003 Jun 2;22(11):2717-28
12773387
Intervirology. 1993;35(1-4):16-25
8407243
J Cell Biol. 1993 Oct;123(1):7-22
8408207
J Virol. 2006 Aug;80(15):7469-80
16840327
Nat Med. 2001 Dec;7(12):1306-12
11726970
Pediatr Infect Dis J. 2005 Feb;24(2):162-6
15702046
In Vitro Cell Dev Biol Anim. 2004 Nov-Dec;40(10):303-11
15780007
Res Commun Chem Pathol Pharmacol. 1992 Jan;75(1):39-48
1352645
J Virol. 1994 Jun;68(6):3667-73
8189504
J Virol. 2006 Aug;80(16):8060-8
16873262
Oncogene. 2004 Apr 12;23(16):2861-74
15077149
Avian Dis. 1994 Jan-Mar;38(1):151-7
8002884
J Gen Virol. 1993 Nov;74 ( Pt 11):2347-55
7504071
Emerg Infect Dis. 2005 Feb;11(2):201-9
15752436
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4
15070767
Avian Dis. 1992 Oct-Dec;36(4):926-31
1485875
J Gen Virol. 1999 Jan;80 ( Pt 1):137-146
9934696
Herz. 1999 May;24(3):189-95
10412642
Biochemistry (Mosc). 2002 May;67(5):534-9
12059772
Glycoconj J. 2006 Feb;23(1-2):101-6
16575527
Cell. 1997 Nov 14;91(4):443-6
9390553
Avian Dis. 1994 Jan-Mar;38(1):22-32
8002896
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S25-30
7551408
Emerg Infect Dis. 2007 May;13(5):708-12
17553248
Virus Res. 2008 Sep;136(1-2):91-7
18550190
J Med Virol. 2001 Mar;63(3):242-6
11170064
Respir Res. 2005 Nov 11;6:135
16283933
J Gen Virol. 1994 Feb;75 ( Pt 2):371-9
8113758
J Vet Med Sci. 2005 Nov;67(11):1193-6
16327236
Chest. 2006 Jan;129(1):156-68
16424427
J Virol. 2007 May;81(10):5181-91
17344280
J Virol. 2001 Sep;75(17):7875-81
11483732
J Virol. 2004 Nov;78(22):12665-7
15507653
Clin Infect Dis. 2002 May 1;34 Suppl 2:S58-64
11938498
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51
11226311
N Engl J Med. 2005 Sep 29;353(13):1374-85
16192482
J Gen Virol. 1997 Nov;78 ( Pt 11):2821-9
9367368
Hepatology. 2005 Feb;41(2):247-56
15660384
Vet Pathol. 1997 Nov;34(6):557-67
9396136
PLoS Pathog. 2005 Sep;1(1):e4
16201016
Nature. 2004 Oct 7;431(7009):703-7
15470432
J Pharmacol Exp Ther. 2000 Sep;294(3):793-9
10945826
J Virol. 1999 Nov;73(11):9679-82
10516084
Am J Pathol. 1997 Oct;151(4):999-1007
9327733
Science. 2005 Oct 7;310(5745):77-80
16210530
J Virol. 2008 Mar;82(6):2741-51
18199656